AUSTIN, Texas, May 24, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ:LMNX) (the «Company»), today announced that its board of directors declared a cash dividend for the second quarter of 2017 of $0.06 per share of common stock payable on July 14, 2017 to stockholders of record as of the close of business on June 23, 2017.

About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at

Harriss Currie
Sr. Vice President of Finance and CFO
[email protected]  

Matthew Scalo
Sr. Director, Investor Relations
[email protected]

Luminex logo. (PRNewsFoto/Luminex Corporation)


To view the original version on PR Newswire, visit:

SOURCE Luminex Corporation